Morgan Stanley downgrades United Therapeutics Corp (UTHR) rating to an Equal-weight
United Therapeutics Corp’s recent filing unveils that its CFO AND TREASURER EDGEMOND JAMES unloaded Company’s shares for reported $2.69 million
United Therapeutics Corp’s recent filing unveils that its CFO AND TREASURER EDGEMOND JAMES unloaded Company’s shares for reported $2.69 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
United Therapeutics Corp’s recently made public that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $93723.0
United Therapeutics Corp’s recently made public that its CFO AND TREASURER EDGEMOND JAMES unloaded Company’s shares for reported $2.71 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, United Therapeutics Corp revealed its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.18
United Therapeutics Corp’s filing revealed that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.2 million
In a filing, United Therapeutics Corp revealed its Director RAYMOND DWEK acquired Company’s shares for reported $1.63 million on Aug
United Therapeutics Corp’s recent filing unveils that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.22
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.